HC5 Stock Overview
A fully integrated real estate investment trust (REIT) and S&P 500 company. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 3/6 |
Financial Health | 2/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Healthpeak Properties, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$20.00 |
52 Week High | US$21.40 |
52 Week Low | US$14.80 |
Beta | 1.12 |
1 Month Change | 1.52% |
3 Month Change | 0% |
1 Year Change | 18.34% |
3 Year Change | -30.63% |
5 Year Change | -39.54% |
Change since IPO | -29.82% |
Recent News & Updates
Recent updates
Shareholder Returns
HC5 | DE Health Care REITs | DE Market | |
---|---|---|---|
7D | 1.0% | 0% | 0% |
1Y | 18.3% | 0% | 0% |
Return vs Industry: HC5 exceeded the German Health Care REITs industry which returned -6% over the past year.
Return vs Market: HC5 exceeded the German Market which returned 15.1% over the past year.
Price Volatility
HC5 volatility | |
---|---|
HC5 Average Weekly Movement | 3.2% |
Health Care REITs Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in DE Market | 0% |
10% least volatile stocks in DE Market | 0% |
Stable Share Price: HC5 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: HC5's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 193 | Scott Brinker | www.healthpeak.com |
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates and develops high-quality real estate focused on healthcare discovery and delivery.
Healthpeak Properties, Inc. Fundamentals Summary
HC5 fundamental statistics | |
---|---|
Market cap | €13.94b |
Earnings (TTM) | €297.87m |
Revenue (TTM) | €2.47b |
46.8x
P/E Ratio5.7x
P/S RatioIs HC5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HC5 income statement (TTM) | |
---|---|
Revenue | US$2.56b |
Cost of Revenue | US$1.03b |
Gross Profit | US$1.53b |
Other Expenses | US$1.22b |
Earnings | US$308.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 03, 2025
Earnings per share (EPS) | 0.44 |
Gross Margin | 59.74% |
Net Profit Margin | 12.08% |
Debt/Equity Ratio | 93.3% |
How did HC5 perform over the long term?
See historical performance and comparisonDividends
5.8%
Current Dividend Yield72%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/02 00:43 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healthpeak Properties, Inc. is covered by 41 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jacob Kilstein | Argus Research Company |
David Rodgers | Baird |
Adam Feinstein | Barclays |